DE602005023973D1 - Verfahren zur diagnose von chronischem stress und verwandten erkrankungen - Google Patents

Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Info

Publication number
DE602005023973D1
DE602005023973D1 DE602005023973T DE602005023973T DE602005023973D1 DE 602005023973 D1 DE602005023973 D1 DE 602005023973D1 DE 602005023973 T DE602005023973 T DE 602005023973T DE 602005023973 T DE602005023973 T DE 602005023973T DE 602005023973 D1 DE602005023973 D1 DE 602005023973D1
Authority
DE
Germany
Prior art keywords
diagnosis
chronic stress
related diseases
stress
analytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005023973T
Other languages
English (en)
Inventor
Marie Asberg
Ake Nygren
Rolf Ekman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Publication of DE602005023973D1 publication Critical patent/DE602005023973D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/485Epidermal growth factor [EGF] (urogastrone)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Control Of Eletrric Generators (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DE602005023973T 2004-04-23 2005-04-14 Verfahren zur diagnose von chronischem stress und verwandten erkrankungen Active DE602005023973D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409153.4A GB0409153D0 (en) 2004-04-23 2004-04-23 Method of diagnosis
PCT/GB2005/001417 WO2005103723A2 (en) 2004-04-23 2005-04-14 Method for the diagnosis of chronic stress and related disorders

Publications (1)

Publication Number Publication Date
DE602005023973D1 true DE602005023973D1 (de) 2010-11-18

Family

ID=32344337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005023973T Active DE602005023973D1 (de) 2004-04-23 2005-04-14 Verfahren zur diagnose von chronischem stress und verwandten erkrankungen

Country Status (6)

Country Link
US (1) US7507584B2 (de)
EP (1) EP1743179B1 (de)
AT (1) ATE483983T1 (de)
DE (1) DE602005023973D1 (de)
GB (1) GB0409153D0 (de)
WO (1) WO2005103723A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102037355A (zh) * 2008-03-04 2011-04-27 里奇诊断学股份有限公司 基于多重生物标记物板块诊断和监测抑郁症
US8747311B2 (en) * 2009-11-19 2014-06-10 Make3Wishes, Llc Method and apparatus for evaluating the effects of internal and external stress influences

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879902A (en) * 1997-06-16 1999-03-09 Neuro-Biotech Inc. Diagnostic methods and kits for the evaluation of the sympathetic nervous system function
US6653135B1 (en) * 2000-09-13 2003-11-25 University Of Maryland Dynamic protein signature assay
BE1014949A3 (fr) * 2001-08-14 2004-07-06 Probiox Procede de detection de stress oxydant et trousse pour sa mise en oeuvre.
US7605128B2 (en) 2002-02-14 2009-10-20 Buck Institute For Age Research Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia

Also Published As

Publication number Publication date
EP1743179B1 (de) 2010-10-06
GB0409153D0 (en) 2004-05-26
ATE483983T1 (de) 2010-10-15
US20080153172A1 (en) 2008-06-26
WO2005103723A2 (en) 2005-11-03
WO2005103723A3 (en) 2006-04-27
US7507584B2 (en) 2009-03-24
EP1743179A2 (de) 2007-01-17

Similar Documents

Publication Publication Date Title
ATE438853T1 (de) Diagnostische testvorrichtung
ATE539675T1 (de) System und verfahren zur bestimmung einer analytenkonzentration mit einer hämatokrit- korrektur
ATE491953T1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
DE60325617D1 (de) Verfahren zur diagnose von bauchspeicheldrüsenkrebs
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
ATE508202T1 (de) Verfahren zur diagnose von brustkrebs
WO2004063713A3 (en) Non-invasive determination of direction and rate of change of an analyte
WO2006073682A3 (en) Diagnostic test
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
WO2008132464A3 (en) Mek5 and related proteins as biomarkers of neurodegenerative diseases
ATE537454T1 (de) Verfahren zum beurteilen von herzinsuffizienz bei patienten mit vorhofflimmern mittels gdf-15
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
RU2008103988A (ru) Способ диагностики рассеяного склероза
ATE478335T1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
ATE483982T1 (de) Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen
ATE406579T1 (de) Verfahren zur diagnose von tumoren
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
DE602006015221D1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
NZ599054A (en) Diagnosis of collagen IX destruction
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein